Circadian secretion pattern of melatonin in Parkinson's disease

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Neural Transmission - Parkinsons Disease and Dementia Section

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02251135PMID 2064730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Some effects of melatonin and the control of its secretion in humans.

  2008cited by this paper
• Circadian variations of adrenergic receptors in the mammalian pineal gland: A review

  2005cited by this paper
• Pineal melatonin functions: possible relevance to Parkinson's disease.

  1990cited by this paper
• The short term secretion pattern of human serum melatonin indicates apulsatile hormone release.

  1989cited by this paper
• Daytime Unresponsiveness of the Human and Syrian Hamster Pineal to Adrenergic Stimulation

  1989cited by this paper
• Plasma, Cerebrospinal Fluid, and Brain Distribution of 14C‐Melatonin in Rat: A Biochemical and Autoradiographic Study

  1988cited by this paper
• Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity.

  1988cited by this paper
• Photoneural regulation of the mammalian pineal gland.

  1985cited by this paper
• Fall in nocturnal serum melatonin during prepuberty and pubescence.

  1984cited by this paper
• Assessment and treatment of chronobiologic disorders using plasma melatonin levels and bright light exposure: the clock-gate model and the phase response curve.

  1984cited by this paper
• Assessment and treatment of chronobiologic disorders using plasma melatonin levels and bright light exposure: the clock-gate model and the phase response curve.

  1984cited by this paper
• Melatonin is a potent modulator of dopamine release in the retina

  1983cited by this paper
• REDUCED NOCTURNAL MELATONIN SECRETION IN CHRONIC SCHIZOPHRENIA: RELATIONSHIP TO BODY WEIGHT

  1982cited by this paper
• Evidence for the presence of melatonin in the human brain.

  1980cited by this paper
• Method for characterization of 24-h temporal variation of blood components.

  1979cited by this paper
• Effect of adrenergic stimulation and blockade on melatonin secretion in the human.

  1979cited by this paper
• The Circadian System of Man: Results of Experiments Under Temporal Isolation

  1979cited by this paper
• Melatonin assays in body fluids.

  1978cited by this paper
• Melatonin in humans physiological and clinical studies.

  1978cited by this paper
• The pineal and psychiatry: a review

  1977cited by this paper
• Melatonin and parkinsonism.

  1973cited by this paper
• Increase in rat pineal melatonin content following L-Dopa administration

  1973cited by this paper
• Melatonin and parkinsonism.

  1972cited by this paper
• Melatonin and Abnormal Movements Induced by L-Dopa in Mice

  1971cited by this paper
• On the effect of melatonin upon human brain. Its possible therapeutic implications.

  1971cited by this paper

• A double-blind, controlled trial of circadian effective light therapy in patients with Parkinson's disease

  2025cites this paper
• Sleep and circadian dysfunction in Parkinson disease: New perspective and opportunities for treatment.

  2025cites this paper
• Dysregulation of melatonin rhythm in Parkinson’s and Huntington’s disease: a systematic review and meta-analysis

  2025influential citation
• More Than Rapid Eye Movement Sleep Behavior Disorder: Sleep Differences in Parkinson’s Disease LRRK2 and GBA Genotypes

  2025cites this paper
• Circadian Intervention Improves Parkinson’s Disease and May Slow Disease Progression: A Ten Year Retrospective Study

  2024cites this paper
• Circadian re-set repairs long-COVID in a prodromal Parkinson’s parallel: a case series

  2024cites this paper
• Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease

  2023cites this paper
• Long-Term Effects of Perinatal Exposure to a Glyphosate-Based Herbicide on Melatonin Levels and Oxidative Brain Damage in Adult Male Rats

  2023cites this paper
• Fine-tuning the circadian system with light treatment for Parkinson’s disease: an in-depth, critical review

  2023cites this paper
• Parkinson’s Disease: A Narrative Review on Potential Molecular Mechanisms of Sleep Disturbances, REM Behavior Disorder, and Melatonin

  2023cites this paper
• Sleep seasonality in alpha-synucleinopathies: A comparative study with non-neurological sleep disorder patients.

  2023cites this paper
• Melatonin Treatment for Sleep Disorders in Parkinson's Disease: A Meta-Analysis and Systematic Review

  2022cites this paper
• Circadian Rhythms in Parkinson’s Disease

  2022cites this paper
• Melatonin as a Reducer of Neuro- and Vasculotoxic Oxidative Stress Induced by Homocysteine

  2021cites this paper
• Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats

  2021cites this paper
• Roles of clock genes in the pathogenesis of Parkinson's disease.

  2021cites this paper
• Circadian rhythms in neurodegenerative disorders

  2021cites this paper
• A Computational Analysis in a Cohort of Parkinson’s Disease Patients and Clock-Modified Colorectal Cancer Cells Reveals Common Expression Alterations in Clock-Regulated Genes

  2021cites this paper
• Circadian Rhythms Disruption

  2020cites this paper
• Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson’s Disease: A Cross-Sectional Study

  2020cites this paper
• Sleep Disorders in Parkinson’s Disease: Management and Case Study

  2020cites this paper
• Circadian rhythm abnormalities

  2020cites this paper
• Shedding light on depressive, anxiety and sleep disorders in Parkinson's disease

  2019cites this paper
• Pathophysiological mechanisms of non-motor features and their role on the pathogenic process in Parkinson's disease

  2019cites this paper
• Melatonin and Major Neurocognitive Disorders: Beyond the Management of Sleep and Circadian Rhythm Dysfunction

  2018cites this paper
• An overview of sleep and circadian dysfunction in Parkinson's disease

  2018cites this paper
• Emerging preclinical interest concerning the role of circadian function in Parkinson's disease.

  2018cites this paper
• Polychromatic Light Exposure as a Therapeutic in the Treatment and Management of Parkinson's Disease: A Controlled Exploratory Trial

  2018cites this paper
• The effect of light exposure on insomnia and nocturnal movement in Parkinson's disease: an open label, retrospective, longitudinal study.

  2018cites this paper
• The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease

  2017cites this paper
• Sleep and Neurodegeneration: A Critical Appraisal.

  2017cites this paper
• Pathology of behavior in PD: What is known and what is not?

  2017cites this paper
• A New Perspective for Parkinson’s Disease: Circadian Rhythm

  2017cites this paper
• Sleep and Movement Disorders

  2017cites this paper
• A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson’s disease

  2016cites this paper
• Circadian dysregulation in Parkinson's disease

  2016cites this paper
• Alteration of Biological Rhythms in Diseases of the Central Dopaminergic System: Focus on Parkinson’s Disease

  2016cites this paper
• Synthesis of 2-arylfuro[3,2-b]pyridines: Effect of the C2-aryl group on melatoninergic activity.

  2016cites this paper
• Circadian system — A novel diagnostic and therapeutic target in Parkinson's disease?

  2016cites this paper
• Neuroendocrine abnormalities in Parkinson's disease

  2016cites this paper
• Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms

  2016cites this paper
• Melatonin attenuates hLRRK2-induced sleep disturbances and synaptic dysfunction in a Drosophila model of Parkinson's disease.

  2016cites this paper
• Circadian disruption: New clinical perspective of disease pathology and basis for chronotherapeutic intervention

  2016cites this paper
• Effects of endogenous melatonin on glutamate and GABA rhythms in the striatum of unilateral 6-hydroxydopamine-lesioned rats.

  2015cites this paper
• Consequences of Circadian Disruption on Neurologic Health.

  2015cites this paper
• Improving Parkinson ’ s Symptoms with Phototherapy

  2015cites this paper
• Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease.

  2015cites this paper
• Antioxidant properties of melatonin and its potential action in diseases.

  2015cites this paper
• The use of melatonin for treating sleep disorders in patients with Parkinson’s disease

  2014cites this paper
• Sleep/wake problems in Parkinson’s disease: pathophysiology and clinicopathologic correlations

  2014cites this paper
• Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease.

  2014cites this paper
• The use of melatonin for treating sleep disorders in patients with Parkinson's disease

  2014cites this paper
• Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.

  2014cites this paper
• Biomarkers in Parkinson's disease (recent update).

  2013cites this paper
• Conséquences du changement d’horaire saisonnier chez le patient atteint de la maladie de Parkinson

  2013cites this paper
• Excessive Daytime Sleepiness in Parkinson’s Disease

  2013cites this paper
• A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson’s disease

  2012cites this paper
• Bright Light Therapy in Parkinson's Disease: An Overview of the Background and Evidence

  2012cites this paper
• Sleep problems in Parkinson’s disease patients

  2011cites this paper
• Sleep-wake changes and cognition in neurodegenerative disease.

  2011cites this paper
• Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection

  2011cites this paper
• Activity—Rest Rhythm Abnormalities in Parkinson's Disease Patients are Related to Dopaminergic Therapy

  2010cites this paper
• Is modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs?

  2010cites this paper
• Sleep Disturbances in Parkinson Disease and Their Potential Role in Heterogeneity

  2010cites this paper
• Dopaminergic augmentation of restless legs syndrome.

  2010cites this paper
• Role of melatonin in neurodegenerative diseases

  2009cites this paper
• Comment to the paper of Medeiros CAM, et al. (2007) J Neurol 254:459–464

  2008cites this paper
• Parkinson's Disease as a Neuroendocrine Disorder of Circadian Function: Dopamine-Melatonin Imbalance and the Visual System in the Genesis and Progression of the Degenerative Process

  2008cites this paper
• Primary and Secondary Features of Parkinson's Disease Improve with Strategic Exposure to Bright Light: A Case Series Study

  2007influential citation
• Augmentation as a treatment complication of restless legs syndrome: Concept and management

  2007cites this paper
• Behavioral and Brain Functions

  2006cites this paper
• Circadian rhythms in RLS.

  2006cites this paper
• Circulating Melatonin Levels: Possible Link Between Parkinson’s Disease and Cancer Risk?

  2006cites this paper
• Power frequency electromagnetic fields, melatonin and the risk of breast cancer.

  2006cites this paper
• Melatonin in Alzheimer's disease and other neurodegenerative disorders

  2006cites this paper
• The therapeutic effects of dopamine replacement therapy and its psychiatric side effects are mediated by pineal function.

  2005cites this paper
• Circadian effects of dopaminergic treatment in restless legs syndrome.

  2004cites this paper
• Study of Circadian Melatonin Secretion Pattern at Different Stages of Parkinson's Disease

  2003cites this paper
• Neuronal and Vascular Plasticity

  2003cites this paper
• Circadian Determinations of Cortisol, Prolactin and Melatonin in Chronic Methyl-Phenyl-Tetrahydropyridine-Treated Monkeys

  2003cites this paper
• The Future of Brain Protection: Natural Alternatives

  2003cites this paper
• Antioxidant strategies in protection against neurodegenerative disorders

  2003cites this paper
• Biologic Rhythms and Parkinson's Disease: A Chronopharmacologic Approach to Considering Fluctuations in Function

  2002cites this paper
• Melatonin levels in Parkinson's disease: drug therapy versus electrical stimulation of the internal globus pallidus.

  1997cites this paper
• Melatonin in Psychiatric and Sleep Disorders

  1995cites this paper
• Circadian secretion pattern of melatonin in de novo Parkinsonian patients: evidence for phase-shifting properties of l-dopa

  1993cites this paper
• The effects of external picoTesla range magnetic fields on the EEG in Parkinson's disease.

  1993cites this paper
• Further observations on the unique efficacy of picoTesla range magnetic fields in Parkinson's disease.

  1993cites this paper
• Weak magnetic fields as a novel therapeutic modality in Parkinson's disease.

  1992cites this paper
• Pathology of behavior in PD : What is known and what is not ?

  year unknowncites this paper